These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7751006

  • 21. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.
    Kast WM, Brandt RM, Sidney J, Drijfhout JW, Kubo RT, Grey HM, Melief CJ, Sette A.
    J Immunol; 1994 Apr 15; 152(8):3904-12. PubMed ID: 7511661
    [Abstract] [Full Text] [Related]

  • 22. Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes.
    Sijts AJ, Ossendorp F, Mengedé EA, van den Elsen PJ, Melief CJ.
    J Immunol; 1994 Jan 01; 152(1):106-16. PubMed ID: 8254184
    [Abstract] [Full Text] [Related]

  • 23. DNA vaccines against HPV-16 E7-expressing tumour cells.
    De Marco F, Hallez S, Brulet JM, Gesché F, Marzano P, Flamini S, Marcante ML, Venuti A.
    Anticancer Res; 2003 Jan 01; 23(2B):1449-54. PubMed ID: 12820408
    [Abstract] [Full Text] [Related]

  • 24. Lessons from T cell responses to virus induced tumours for cancer eradication in general.
    Melief CJ, Kast WM.
    Cancer Surv; 1992 Jan 01; 13():81-99. PubMed ID: 1423326
    [Abstract] [Full Text] [Related]

  • 25. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.
    Ishioka GY, Fikes J, Hermanson G, Livingston B, Crimi C, Qin M, del Guercio MF, Oseroff C, Dahlberg C, Alexander J, Chesnut RW, Sette A.
    J Immunol; 1999 Apr 01; 162(7):3915-25. PubMed ID: 10201910
    [Abstract] [Full Text] [Related]

  • 26. E7 oncoprotein of human papillomavirus type 16 expressed constitutively in the epidermis has no effect on E7-specific B- or Th-repertoires or on the immune response induced or sustained after immunization with E7 protein.
    Herd K, Fernando GJ, Dunn LA, Frazer IH, Lambert P, Tindle RW.
    Virology; 1997 Apr 28; 231(1):155-65. PubMed ID: 9143315
    [Abstract] [Full Text] [Related]

  • 27. Synthetic peptides induce a cytotoxic response against human papillomavirus type-18.
    Castellanos MR, Hayes RL, Maiman MA.
    Gynecol Oncol; 2001 Jul 28; 82(1):77-83. PubMed ID: 11426965
    [Abstract] [Full Text] [Related]

  • 28. CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma.
    Mandelboim O, Berke G, Fridkin M, Feldman M, Eisenstein M, Eisenbach L.
    Nature; 1994 May 05; 369(6475):67-71. PubMed ID: 8164742
    [Abstract] [Full Text] [Related]

  • 29. Peptide-priming of cytolytic T cell immunity in vivo using beta 2-microglobulin as an adjuvant.
    Rock KL, Fleischacker C, Gamble S.
    J Immunol; 1993 Feb 15; 150(4):1244-52. PubMed ID: 8381832
    [Abstract] [Full Text] [Related]

  • 30. A single amino acid substitution improves the in vivo immunogenicity of the HPV16 oncoprotein E7(11-20) cytotoxic T lymphocyte epitope.
    Schreurs MW, Kueter EW, Scholten KB, Lemonnier FA, Meijer CJ, Hooijberg E.
    Vaccine; 2005 Jul 01; 23(31):4005-10. PubMed ID: 15963358
    [Abstract] [Full Text] [Related]

  • 31. Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7.
    Daemen T, Regts J, Holtrop M, Wilschut J.
    Gene Ther; 2002 Jan 01; 9(2):85-94. PubMed ID: 11857066
    [Abstract] [Full Text] [Related]

  • 32. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides.
    Zhou X, Abdel Motal UM, Berg L, Jondal M.
    Eur J Immunol; 1992 Dec 01; 22(12):3085-90. PubMed ID: 1446701
    [Abstract] [Full Text] [Related]

  • 33. Characterization of mouse MAGE-derived H-2Kb-restricted CTL epitopes.
    Eggert AO, Andersen MH, Voigt H, Schrama D, Kämpgen E, Straten PT, Becker JC.
    Eur J Immunol; 2004 Nov 01; 34(11):3285-90. PubMed ID: 15384049
    [Abstract] [Full Text] [Related]

  • 34. T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16.
    Azoury-Ziadeh R, Herd K, Fernando GJ, Frazer IH, Tindle RW.
    Viral Immunol; 1999 Nov 01; 12(4):297-312. PubMed ID: 10630789
    [Abstract] [Full Text] [Related]

  • 35. Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein.
    Bartholomew JS, Stacey SN, Coles B, Burt DJ, Arrand JR, Stern PL.
    Eur J Immunol; 1994 Dec 01; 24(12):3175-9. PubMed ID: 7805746
    [Abstract] [Full Text] [Related]

  • 36. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
    Hetttihewa LM.
    Int Immunopharmacol; 2003 Oct 01; 3(10-11):1401-11. PubMed ID: 12946436
    [Abstract] [Full Text] [Related]

  • 37. A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells.
    Yanuck M, Carbone DP, Pendleton CD, Tsukui T, Winter SF, Minna JD, Berzofsky JA.
    Cancer Res; 1993 Jul 15; 53(14):3257-61. PubMed ID: 7686815
    [Abstract] [Full Text] [Related]

  • 38. Peptide selection by MHC class I molecules.
    Schumacher TN, De Bruijn ML, Vernie LN, Kast WM, Melief CJ, Neefjes JJ, Ploegh HL.
    Nature; 1991 Apr 25; 350(6320):703-6. PubMed ID: 1708852
    [Abstract] [Full Text] [Related]

  • 39. Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein.
    Sadovnikova E, Zhu X, Collins SM, Zhou J, Vousden K, Crawford L, Beverley P, Stauss HJ.
    Int Immunol; 1994 Feb 25; 6(2):289-96. PubMed ID: 7512375
    [Abstract] [Full Text] [Related]

  • 40. Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells.
    Franksson L, Petersson M, Kiessling R, Kärre K.
    Eur J Immunol; 1993 Oct 25; 23(10):2606-13. PubMed ID: 8405061
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.